Total liabilities · 2011–2025
Supernus Pharmaceuticals total liabilities
$391M+17.6% · FY2025
Supernus Pharmaceuticals (SUPN) reported $391M in total liabilities for fiscal 2025, +17.6% year on year.
| Fiscal year | Total liabilities | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $391M | +17.6% | Open → |
| FY20242024-12-31 | $332M | −6.7% | Open → |
| FY20232023-12-31 | $356M | −56.4% | Open → |
| FY20222022-12-31 | $816M | −6.5% | Open → |
| FY20212021-12-31 | $873M | +15.0% | Open → |
| FY20202020-12-31 | $759M | +34.4% | Open → |
| FY20192019-12-31 | $565M | +7.6% | Open → |
| FY20182018-12-31 | $525M | +234.3% | Open → |
| FY20172017-12-31 | $157M | +33.2% | Open → |
| FY20162016-12-31 | $118M | +17.1% | Open → |
| FY20152015-12-31 | $101M | +4.7% | Open → |
| FY20142014-12-31 | $96.1M | +23.9% | Open → |
| FY20132013-12-31 | $77.5M | +112.9% | Open → |
| FY20122012-12-31 | $36.4M | −17.8% | Open → |
| FY20112011-12-31 | $44.3M | — | Open → |
Total liabilities — Total liabilities is everything the company owes at the balance-sheet date — debt, payables, deferred revenue and provisions together. Where a filer does not tag it, we calculate it as total assets minus total equity and label the figure as calculated.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +16.8%
Total liabilities at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Supernus Pharmaceuticals total liabilities |url=https://companiesranked.com/en/company/supernus-pharmaceuticals/total-liabilities |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Supernus Pharmaceuticals total liabilities. CompaniesRanked. https://companiesranked.com/en/company/supernus-pharmaceuticals/total-liabilitiesBibTeX
@misc{companiesranked-en-company-supernus-pharmaceuticals-total-liabilities-2026,
author = {{CompaniesRanked}},
title = {{Supernus Pharmaceuticals total liabilities}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/supernus-pharmaceuticals/total-liabilities}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001356576-26-000037 · August 3, 2026
{{cite web |title=Supernus Pharmaceuticals total liabilities — 10-Q (0001356576-26-000037) |url=https://www.sec.gov/Archives/edgar/data/1356576/000135657626000037/supn-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-03}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.